The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

The pouches are used by less than 2% of US teens, the FDA said in granting the application allowing them to continue to be sold.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.